Blackstone’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.7M Buy
+435,320
New +$9.08M 0.02% 103
2025
Q2
– Sell
-27,289
Closed -$2.4M – 175
2025
Q1
$2.4M Buy
27,289
+13,016
+91% +$1.14M 0.01% 111
2024
Q4
$1.32M Buy
+14,273
New +$1.23M 0.01% 120

Other funds holding JBIO

Blackstone's JBIO Position: Q2 2026 in Review

Blackstone opened a new position in Jade Biosciences (JBIO) in Q2 2026: 435,320 shares worth $9.7M. The stake represents 0.02% of the portfolio and ranks #103 among its holdings. This is a return to the name: Blackstone previously reported a position in JBIO as recently as Q1 2025.

Blackstone first reported a position in JBIO in Q4 2024 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Blackstone held 435,320 shares of Jade Biosciences worth $9.7M as of Q2 2026.
  • Jade Biosciences was a new Blackstone position in Q2 2026.
  • Jade Biosciences made up 0.02% of Blackstone's portfolio in Q2 2026, its #103 holding.
  • Blackstone first reported a position in Jade Biosciences in Q4 2024 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.